Fibrate Medications
- PMID: 31613536
- Bookshelf ID: NBK547756
Fibrate Medications
Excerpt
Fibrates are a class of drugs utilized in the management and treatment of dyslipidemia. This activity reviews the indications, action, and contraindications for fibrates as a valuable agent in managing serum cholesterol levels. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., monitoring, relevant interactions, etc.) pertinent for members of the healthcare team involved in the care of patients with atherogenic dyslipidemia and related conditions.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
Similar articles
-
Therapeutic Uses of Diuretic Agents.2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32491770 Free Books & Documents.
-
Pitavastatin.2023 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32491334 Free Books & Documents.
-
Reverse Transcriptase Inhibitors.2023 Jun 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jun 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31855348 Free Books & Documents.
-
Mercaptopurine.2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32491552 Free Books & Documents.
-
Triglyceride Lowering Drugs.2024 Jan 18. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2024 Jan 18. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 28402615 Free Books & Documents. Review.
References
-
- Shepherd J. Mechanism of action of fibrates. Postgrad Med J. 1993;69 Suppl 1:S34-41. - PubMed
-
- Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998 Nov 10;98(19):2088-93. - PubMed
-
- Davidson MH, Armani A, McKenney JM, Jacobson TA. Safety considerations with fibrate therapy. Am J Cardiol. 2007 Mar 19;99(6A):3C-18C. - PubMed
-
- Škop V, Trnovská J, Oliyarnyk O, Marková I, Malínská H, Kazdová L, Zídek V, Landa V, Mlejnek P, Šimáková M, Kůdela M, Pravenec M, Šilhavý J. Hepatotoxic effects of fenofibrate in spontaneously hypertensive rats expressing human C-reactive protein. Physiol Res. 2016 Dec 13;65(6):891-899. - PubMed
Publication types
LinkOut - more resources
Full Text Sources